Exacerbation of tinea corporis during treatment with 1% clotrimazole/0.05% betamethasone diproprionate (Lotrisone)
Reynolds
R D
RD
Boiko
S
S
Lucky
A W
AW
D000038:Abscess / Q000139:chemically induced* / Q000473:pathology; D001623:Betamethasone / Q000009:adverse effects / Q000031:analogs & derivatives*; D002648:Child; D003022:Clotrimazole / Q000009:adverse effects*; D003881:Dermatomycoses / Q000139:chemically induced* / Q000473:pathology; D004338:Drug Combinations; D005260:Female; D006099:Granuloma / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007717:Knee; D014005:Tinea / Q000188:drug therapy*
D004338:Drug Combinations; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D003022:Clotrimazole